Learn
Semaglutide is a GLP-1 medicine that quiets appetite. Here is what that means, and what a telehealth visit actually decides.
Semaglutide mimics GLP-1, a hormone your gut already releases when you eat. Food stays in the stomach longer. Hunger gets quieter. People describe forgetting a snack, or looking at a full plate and stopping. Some people mostly notice nausea. Both are common reports. Neither is a promise about the scale.
You will see the same molecule under brand names. Ozempic and Wegovy are specific products with their own supply and their own labels. A Thrivelab clinician is not a checkout lane for a brand. They decide whether this class of medicine fits your history, and what a pharmacy can actually fill.
The free assessment opens a file. The 45-minute intake is the appointment. Bring medicines, prior diets, and any labs you can export. Bloodwork, when it is ordered, happens at a local Quest or Labcorp. Nothing ships until a clinician licensed in your state says it should.
Follow-up is the part the ads skip. Nausea, constipation, a week you could not eat. You report it. The plan changes or stops. A coordinator can find a box. They cannot tell you to ignore vomiting.
Trial averages do not belong on a page that has not met you. Your clinician can talk about the evidence that matches your chart. If semaglutide is a poor fit, the useful outcome of the visit is a no.
Eat protein, drink water, and do not treat an inability to keep fluids down as a sign of success. That is a call, the same day.
Reviewed by Jonathan Larson MDPC clinicians. Educational only — not medical advice.
No cost · No obligation
Start online in minutes. A licensed clinician reviews your goals and confirms what's right for you — no obligation.